Experts believe that pharma will continue as normal due to the scientific justification of running diverse clinical trials.

Novartis AG (NYSE:NVS), a global healthcare powerhouse with a market capitalization of $208.27 billion, has recently transformed into a pure-play pharmaceutical company, sharpening its focus on its ...

Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Brad Leonard ...

Carl Rizzuto, Versant Ventures managing director, joins 'Fast Money' to talk the impact of tariffs on healthcare.

Europeans are being warned of the dangers of counterfeit medications after police squads across the continent reported ...

Ligand Pharmaceuticals stock is on the rise with optimistic analyst ratings and a plan for 20% annual revenue growth. Learn ...

Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total ...

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...

Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November, ...

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...

Ascendis Pharma boasts several commercial stage products. Read why ASND stock is an interesting speculative investment ...